There were 1,553 press releases posted in the last 24 hours and 399,925 in the last 365 days.

Research Breakthrough May Add Potent New Weapon in Fight Against Dangerous Flu Strains

May 26, 2010 /EIN Presswire/ -- Futuristic research involving gold nanorods could result in a new family of antiviral medicines that treat a broad range of infectious diseases.

The current issue of the Proceedings of the National Academy of Sciences features a paper describing research conducted jointly by scientists at the University of Buffalo and the US Centers for Disease Control and Prevention that effectively delivers potent immune-boosting payloads by gold nanorods.

Read more at Nanotechnology News Today:
Nanorod news - http://nanotech.einnews.com/news/nanorod

Located at http://nanotech.einnews.com, Nanotechnology News Today is a service of EIN News, a global news monitoring service for researchers and analysts. Using a combination of proprietary search technology and human editing, EIN News delivers the latest nanotechnology news from more than 7,000 news sites from around the world. The latest news updates on these topics are also available in email and RSS formats.

About EIN Presswire
The EIN Presswire press release service is a news-syndication solution that distributes news to more than 10 million visitors annually at EIN News and millions more through its press release distribution partners. A news source for journalists, decision-makers and industry professionals worldwide, EIN Presswire targets press releases to a wide array of worldwide business professionals through more than 90 industry channels. EIN Presswire also offers affiliate network opportunities and news distribution to tens of thousands of news subscribers daily. Read the press release live feed at http://www.einpresswire.com and the latest world news at http://www.einnews.com.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.